
| Revenue | Less than $1 million See Exact Annual Revenue |
|---|---|
| Employees | 1 - 10Exact Company Size |
| Primary Industry | 5417 Scientific Research & Development Services |
| Address | 1812 Ashland Ave Suite 100 Baltimore, MD 21205 |
| Windmil Therapeutics | Revenue Est. ($ Million) | Growth Rate (%) | # Employees |
|---|---|---|---|
| 2025 | Less than $1 million Details in Premium Report | ||
| 2024 | |||
| 2023 | |||
| 2021 | |||
| 2020 | |||
| 2019 | |||
|
1-Year Growth Rate: 3-Year Growth Rate (CAGR): | ![]() |
| Windmil Therapeutics P&L | $ Millions |
|---|---|
| Revenue (Sales) | ![]() |
| Cost of Goods Sold | |
| Gross Profit | |
Operating Expenses | |
| Advertising | |
| Salaries and wages | |
| Other Operating Expenses | |
| Total Operating Expenses | |
| Operating Income | |
| EBITDA | |
| EBIT (Earnings Before Interest and Taxes) | |
| Net Profit | |
| Trademark | Date |
|---|---|
| MILSGEN T cell therapy services; cell therapy services; T cell therapy services, namely, providing adaptive cell therapy services; providing information in the field of cancer treatment; providing information in the field of treatment of cancer via a website; providing a website via a global computer network featuring information in the fields of health, cancer treatment, T cell therapy, immunology; medical services relating to the removal, treatment and processing of lymphocytes; medical services relating to the removal, treatment and processing of human cells | 05/05/2021 |
| TCR-MILS pharmaceutical preparations and substances to provide immune activity to fight an existing disease; pharmaceutical preparations and substances, namely, preparations that involve removal, manipulation, activation, expansion and reintroduction of t-cells | 04/12/2021 |
| GM-MILS T cell therapy services; T cell therapy services, namely, providing adaptive cell therapy services; providing information in the field of cancer treatment; providing information in the field of treatment of cancer via a website; providing a website via a global computer network featuring information in the fields of health, cancer treatment, T cell therapy, immunology; medical services relating to the removal, treatment and processing of lymphocytes; medical services relating to the removal, treatment and processing of human cells | 04/12/2021 |
| Company | Headquarters | Revenue ($ MM) |
|---|---|---|
| LEIDOS | Denver, CO | 100 |
| NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA | Albuquerque, NM | 30 |
| INC RESEARCH | Raleigh, NC | 27 |
| RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORK | Albany, NY | 17 |
| FLUOR MARINE PROPULSION | West Mifflin, PA | 15 |
| SYNEOS HEALTH | Raleigh, NC | 13 |
| ILLUMINA | San Diego, CA | 12 |
| UT-BATTELLE | Oak Ridge, TN | 11 |
| PRA HOLDINGS | Raleigh, NC | 11 |
| Company | Headquarters | Revenue ($ MM) |
|---|---|---|
| PGDX | Baltimore, MD | 100 |
| LIEBER INSTITUTE | Baltimore, MD | 34 |
| PERSONAL GENOME DIAGNOSTICS | Baltimore, MD | 30 |
| MARITIME APPLIED PHYSICS | Curtis Bay, MD | 16 |
| FRIENDS RESEARCH INSTITUTE | Baltimore, MD | 15 |
| RCT SYSTEMS | Baltimore, MD | 14 |
| Company | Headquarters | Revenue ($ MM) |
|---|---|---|
| AVIDEA TECHNOLOGIES | Baltimore, MD | 100 |
| ONCOSPACE | Baltimore, MD | 28 |
| EPIWATCH | Baltimore, MD | 11 |
| PATHOVAX | Baltimore, MD | 0 |
| REZIGENE | Baltimore, MD | 0 |
| Company | Revenue ($ MM) |
|---|---|
![]() | |